NCT01347255View on ClinicalTrials.gov

A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Psoriasis Vulgaris
Interventions
DRUG

LEO90100 cutaneous spray, ointment

once daily application, 4 weeks

DRUG

LEO 90100 cutaneous spray, ointment, vehicle with betamethasone dipropionate

once daily application, 4 weeks

DRUG

LEO 90100 cutaneous spray, ointment, vehicle

once daily application, 4 weeks

DRUG

Daivobet® ointment

once daily application, 4 weeks

Trial Locations (1)

Cedex 3

Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD), Nice

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY

NCT01347255 - A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris | Biotech Hunter | Biotech Hunter